Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium oxybate for vigilance impairment in narcolepsy
NL-OMON30579Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium oxybate in narcolepsy (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Feasibility of 7-day portable vigilance testing, Portable vigilance performance in narcolepsy versus healthy controls and 6 more. Planned start May 2006; status: not yet recruiting.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NL-OMON30579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30579.